Prospera Capital Management’s AbbVie ABBV Stock Holding History

Prospera Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$362K	Buy	+1,384	New	+$355K	0.09%	47

Other funds holding ABBV

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

Prospera Capital Management's ABBV Position: Q3 2026 in Review

Prospera Capital Management opened a new position in AbbVie (ABBV) in Q3 2026: 1,384 shares worth $362K. The stake represents 0.09% of the portfolio and ranks #47 among its holdings.

3,749 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Prospera Capital Management held 1,384 shares of AbbVie worth $362K as of Q3 2026.
AbbVie was a new Prospera Capital Management position in Q3 2026.
AbbVie made up 0.09% of Prospera Capital Management's portfolio in Q3 2026, its #47 holding.
3,749 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Prospera Capital Management's 13F filing for Q3 2026, filed 13 Oct 2026.